New hope for kids with tough brain cancers: immune cell therapy trial opens
NCT ID NCT07087002
Summary
This early-stage trial is testing a new cell therapy for children and young adults with aggressive brain tumors that have come back or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target a protein (GPC2) on the tumor, and then infuse them directly into the fluid around the brain. The main goals are to see if the treatment can be made safely and to check for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MEDULLOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lucile Packard Children's Hospital Stanford
RECRUITINGPalo Alto, California, 94304, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.